A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Clinical trial NCT00642824 · TERMINATED

Trial details

NCT number: NCT00642824
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Cancer

Start date: 2007-05-01
Primary completion: 2009-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.